Obecabtagene Autoleucel (Obe-Cel) for Adult Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in the Open-Label, Multi-Center, Global, Single-Arm, Phase Ib/II FELIX Study: the Impact of Bridging Therapies on CAR T-Cell Expansion and Persistence